European Psychiatry,
Journal Year:
2023,
Volume and Issue:
66(1)
Published: Jan. 1, 2023
Abstract
Background
Accumulating
evidence
indicates
that
a
variety
of
distal
and
proximal
factors
might
impact
risk
suicide.
However,
the
association
between
both
groups
remains
unknown.
Therefore,
in
present
study,
we
aimed
to
investigate
interplay
correlates
current
suicidal
ideation.
Methods
A
total
3,000
individuals
(aged
18–35
years,
41.7%
males),
who
had
reported
negative
history
psychiatric
treatment,
were
enrolled
through
an
online
computer-assisted
web
interview.
Self-reports
administered
measure:
(a)
factors:
childhood
trauma
(CT),
reading
disabilities
(RDs),
symptoms
attention-deficit/hyperactivity
disorder
(ADHD),
lifetime
non-suicidal
self-injury
(NSSI),
problematic
substance
use
as
well
family
schizophrenia
mood
disorders;
(b)
depressive
symptoms,
psychotic-like
experiences
(PLEs),
insomnia;
(c)
sociodemographic
characteristics.
Results
Suicidal
ideation
was
directly
associated
with
unemployment,
being
single,
higher
level
RD,
NSSI
severity
PLEs,
depression,
insomnia.
The
fully
(a
CT
ADHD)
or
partially
RD)
mediated
by
(PLEs,
insomnia).
Conclusions
Main
findings
from
this
study
posit
role
related
neurodevelopmental
disorders,
shaping
suicide
risk.
Their
effects
be
Evidence-Based Mental Health,
Journal Year:
2022,
Volume and Issue:
25(4), P. 148 - 155
Published: Sept. 26, 2022
Question
Effective
prevention
of
suicide
requires
a
comprehensive
understanding
risk
factors.
Study
selection
and
analysis
Five
databases
were
systematically
searched
to
identify
psychological
autopsy
studies
(published
up
February
2022)
that
reported
on
factors
for
mortality
among
adults
in
the
general
population.
Effect
sizes
pooled
as
odds
ratios
(ORs)
using
random-effects
models
each
factor
examined
at
least
three
independent
samples.
Findings
A
total
37
case–control
from
23
countries
included,
providing
data
40
5633
cases
7101
controls.
The
magnitude
effect
varied
substantially
both
between
within
domains.
Clinical
had
strongest
associations
with
suicide,
including
any
mental
disorder
(OR=13.1,
95%
CI
9.9
17.4)
history
self-harm
(OR=10.1,
6.6
15.6).
By
comparison,
smaller
other
domains
relating
sociodemographic
status,
family
history,
adverse
life
events
(OR
range
2–5).
Conclusions
wide
predisposing
precipitating
are
associated
population,
but
clear
differences
their
relative
strength.
PROSPERO
registration
number
CRD42021232878.
JAMA Network Open,
Journal Year:
2021,
Volume and Issue:
4(6), P. e2113513 - e2113513
Published: June 14, 2021
Importance
Disparities
by
sex
and
racial/ethnic
group
in
suicide
death
rates
are
present
US
adolescents.
Whether
disparities
extend
to
groups
targeted
for
prevention
efforts,
namely,
those
with
suicidal
ideation
or
nonfatal
attempts,
is
unknown.
Objective
To
examine
differences
temporal
trends
between
attempts
adolescents
from
1991
through
2019
race/ethnicity
subgroups.
Design,
Setting,
Participants
A
cross-sectional
analysis
of
the
national
Youth
Risk
Behavior
Survey,
weighted
represent
2019,
included
183
563
high-school
students
grades
9
12.
Data
were
analyzed
September
16,
2020,
April
12,
2021.
Survey-weighted
prevalence
estimates,
annual
percentage
changes
(APCs)
average
APC
survey-weighted
constructed
self-reported
ideation,
plan,
each
survey
(non-Hispanic
White,
non-Hispanic
Black,
Hispanic,
Asian
Pacific
Islander
Native
Hawaiian,
American
Indian/Alaska
Native),
their
(sex
×
race/ethnicity).
Results
In
(unweighted)
(mean
[SD]
age,
16.07
[1.23]
years;
94
282
females
[weighted
percentage,
49.4%;
95%
CI,
48.8%-50.1%]),
decreased
(from
19.4%
15.8%;
0.7%-0.9%),
whereas
increased
7.3%
8.9%;
1.0%-1.4%).
Joinpoint
regression
indicated
a
−3.1%
(95%
−3.7%
−2.6%)
decrease
2009,
followed
3.4%
increase
1.9%
-4.8%)
2009
2019.
Decreasing
increasing
showed
modestly
different
turning
points
female
(1991-2009,
2009-2019),
White
Hispanic
(1991-2007,
2007-2019),
Black
(1991-2005,
2005-2019)
Although
no
significant
observed
male
(68.4%
increase;
0.2%
-1.2%)
(79.7%
0.1%-1.5%)
had
greater
increases
attempts.
Interaction
revealed
(APC,
4.3%;
1.5%-7.1%),
2005
3.4%;
1.4%-5.4%),
3.3%;
1.0%-5.6%)
3.1%;
0.3%-6.0%).
Conclusions
Relevance
The
findings
this
study
show
apparent
Increases
since
individuals;
represented
largest
Evidence-based
programs
need
be
tailored
calling
diversification
health
care
system,
school,
community
approaches.
American Journal of Psychiatry,
Journal Year:
2023,
Volume and Issue:
180(10), P. 723 - 738
Published: Oct. 1, 2023
Suicidal
behavior
is
heritable
and
a
major
cause
of
death
worldwide.
Two
large-scale
genome-wide
association
studies
(GWASs)
recently
discovered
cross-validated
significant
(GWS)
loci
for
suicide
attempt
(SA).
The
present
study
leveraged
the
genetic
cohorts
from
both
to
conduct
largest
GWAS
meta-analysis
SA
date.
Multi-ancestry
admixture-specific
meta-analyses
were
conducted
within
groups
African,
East
Asian,
European
ancestry
admixtures.
Journal of the Royal Society of Medicine,
Journal Year:
2021,
Volume and Issue:
114(10), P. 473 - 479
Published: Sept. 22, 2021
Objective
The
objective
of
this
research
was
to
evaluate
the
impact
federal,
public
health
and
social
support
programs
on
national
suicide
rates
in
Canada.
Design
Cross-sectional
study.
Setting
Canadian
National
Database
(i.e.,
Statistics
Canada)
Statista.
Participants
Population-level
data,
economic
consumer
market
data.
Main
Outcome
Measures
Suicide
mortality
population
data
unemployment
were
obtained
from
available
statistical
databases
(e.g.
Canada).
We
quantified
rate
by
dividing
total
number
deaths
expressed
as
a
per
100,000
population.
Results
Overall
decreased
Canada
10.82
March
2019
-
February
2020
period
7.34
(i.e.
absolute
difference
1300
deaths)
2021
period.
overall
changed
an
average
monthly
5.7%
9.5%
2020.
Conclusion
Our
results
indicate
that
for
first
post-pandemic
interval
evaluated
2021),
against
background
extraordinary
measures
intended
mitigate
community
spread
COVID-19.
An
externality
significant
rise
distress.
suggest
government
interventions
broadly
aim
reduce
insecurity
economic,
housing,
health),
timely
psychiatric
services,
should
be
prioritised
part
reduction
strategy,
not
only
during
but
after
termination
COVID-19
pandemic.
European Neuropsychopharmacology,
Journal Year:
2023,
Volume and Issue:
75, P. 15 - 30
Published: June 24, 2023
Biomarkers
that
can
differentiate
between
psychiatric
disorders
with
and
without
suicidal
behavior
history
from
each
other
healthy
volunteers
may
explain
part
of
the
pathogenesis
behavior.
We
conducted
hitherto
largest
meta-analysis
comparing
immune
biomarkers
subjects
suicide
attempt
or
death
by
suicide.
The
study
protocol
was
registered
PROSPERO,
CRD42020212841.
Standardized
mean
differences
(SMD)
were
pooled
random-effects
models.
Heterogeneity
studies
assessed
I
Child & Family Social Work,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 9, 2025
ABSTRACT
Siblings
of
individuals
with
neurodevelopmental
conditions
(NDCs)
are
at
increased
genetic
and
environmental
risk
for
poorer
psychosocial
neurocognitive
outcomes
compared
to
control
groups
siblings
without
NDCs.
This
narrative
review
presents
findings
date
on
NDC
sibling
wellbeing,
focusing
the
objective
cognitive
functioning
persons
a
range
The
transdiagnostic
individual‐level
resilience
factors
impacting
siblings,
their
associations
mental
health,
can
be
modelled
interpreted
holistically
within
novel
neurobiopsychosocial
framework
wellbeing.
Enriched
by
community
consultation,
Sibling
Project
was
first
exploration
self‐reported
influencing
health
cross‐sectionally
over
time,
adopting
dynamic
bioecological
approach
identify
salient
targets
intervention
pathways
future
research.
American Journal of Psychiatry,
Journal Year:
2021,
Volume and Issue:
178(11), P. 1060 - 1069
Published: July 14, 2021
The
authors
examined
the
extent
to
which
genetic
and
environmental
etiology
of
suicide
attempt
death
is
shared
or
unique.The
used
Swedish
national
registry
data
for
a
large
cohort
twins,
full
siblings,
half
siblings
(N=1,314,990)
born
between
1960
1990
followed
through
2015.
They
conducted
twin-family
modeling
estimate
heritability
each
outcome,
along
with
correlations
them.
further
assessed
relationship
by
young
people
compared
adults.In
bivariate
models,
were
moderately
heritable
among
both
women
(attempt:
additive
variance
component
[A]=0.52,
95%
CI=0.44,
0.56;
death:
A=0.45,
CI=0.39,
0.59)
men
A=0.41,
CI=0.38,
0.49;
A=0.44,
CI=0.43,
0.44).
outcomes
substantially,
but
incompletely,
genetically
correlated
(women:
rA=0.67,
CI=0.55,
0.67;
men:
rA=0.74,
CI=0.63,
0.87).
Environmental
weaker
rE=0.36,
CI=0.29,
0.45;
rE=0.21,
CI=0.19,
0.27).
Heritability
was
stronger
ages
10-24
(A=0.55-0.62)
than
those
age
25
older
(A=0.36-0.38),
correlation
during
youth
adulthood
(rA=0.79,
CI=0.72,
0.79)
(rA=0.39,
CI=0.26,
0.47).The
etiologies
are
partially
overlapping,
exhibit
modest
sex
differences,
shift
across
life
course.
These
differences
must
be
considered
when
developing
prevention
efforts
risk
prediction
algorithms.
Where
feasible,
should
separately
rather
collapsed,
including
in
context
gene
identification
efforts.
American Journal of Psychiatry,
Journal Year:
2022,
Volume and Issue:
179(4), P. 298 - 304
Published: April 1, 2022
Understanding
the
effectiveness
of
medication
treatment
for
opioid
use
disorder
to
decrease
risk
suicide
mortality
may
inform
clinical
and
policy
decisions.
The
authors
sought
describe
effect
medications
(MOUD)
on
mortality.This
was
a
retrospective
cohort
study
in
Department
Veterans
Affairs
(VA)
patients
from
2003
2017.
linked
three
data
sources:
VA
Corporate
Data
Warehouse,
Centers
Medicare
Medicaid
Services
Claims
Data,
VA-Department
Defense
Mortality
Repository.
exposure
interest
MOUD,
including
starting
periods
(first
14
days
treatment),
stopping
off
stable
time
treatment,
(reference
category).
main
outcome
measures
included
mortality,
external-cause
all-cause
5
years
following
initiation
MOUD.Over
60,000
received
MOUD.
Patients
were
typically
male
(92.8%)
their
mean
age
46.5
(SD=13.1).
After
adjusting
demographic
characteristics,
mental
health
physical
conditions,
care
utilization,
adjusted
hazard
ratio
during
MOUD
0.45
(95%
CI=0.32,
0.63)
0.35
CI=0.31,
0.40)
0.34
0.37)
mortality.
associated
with
an
0.55
CI=0.25,
1.21),
1.38
CI=0.82,
2.34).Treatment
substantial
reduction
as
well
external
causes